{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:15:34Z","timestamp":1778728534410,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jsat.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T15:02:13Z","timestamp":1489071733000},"page":"67-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder"],"prefix":"10.1016","volume":"77","author":[{"given":"Michael D.","family":"Stein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon R.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genie L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2017.03.002_bb0005","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996\u20132013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"American Journal of Public Health"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: A meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Archives of Clinical Neuropsychology"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10550880802122620","article-title":"The impact of benzodiazepine use on methadone maintenance treatment outcomes","volume":"27","author":"Brands","year":"2008","journal-title":"Journal of Addictive Diseases"},{"issue":"2","key":"10.1016\/j.jsat.2017.03.002_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/10550887.2011.554776","article-title":"Factors associated with frequent utilization of crisis substance use detoxification services","volume":"30","author":"Carrier","year":"2011","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2017.03.002_bb0030","series-title":"Centers for Disease Control and Prevention-ranging online data for epidemiologic research (WONDER)","author":"CDC","year":"2016"},{"key":"10.1016\/j.jsat.2017.03.002_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-244X-11-90","article-title":"Benzodiazepine use and misuse among patients in a methadone program","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jsat.2017.03.002_bb0040","series-title":"Drug-poisoning deaths involving opioid analgesics: United States, 1999\u20132011","first-page":"1","volume":"166","author":"Chen","year":"2014"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0045","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1465-3362.2009.00101.x","article-title":"Benzodiazepine use among heroin users: Baseline use, current use and clinical outcome","volume":"29","author":"Darke","year":"2010","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/j.jsat.2017.03.002_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1360-0443.2000.95224511.x","article-title":"The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study","volume":"95","author":"de las Cuevas","year":"2000","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0060","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","article-title":"Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: Findings of the German randomized controlled trial","volume":"112","author":"Eiroa-Orosa","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.jsat.2017.03.002_bb0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jsat.2009.03.006","article-title":"Self-perceived motivation for benzodiazepine use and behavior related to benzodiazepine use among opiate-dependent patients","volume":"37","author":"Fatseas","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugpo.2014.07.013","article-title":"High risk and little knowledge: Overdose experiences and knowledge among young adult nonmedical prescription opioid users","volume":"26","author":"Frank","year":"2015","journal-title":"The International Journal on Drug Policy"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2017.03.002_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0376-8716(98)00175-6","article-title":"Characteristics of benzodiazepine abuse in methadone maintenance treatment patients: A 1year prospective study in an Israeli clinic","volume":"55","author":"Gelkopf","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/0897190013515001","article-title":"Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics","volume":"27","author":"Jann","year":"2014","journal-title":"Journal of Pharmacy Practice"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2017.03.002_bb0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","article-title":"Polydrug abuse: A review of opioid and benzodiazepine combination use","volume":"125","author":"Jones","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","article-title":"Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users","volume":"87","author":"Kerr","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.03.002_bb0095","unstructured":"Kindy, K., & Keating, D. (2016, Aug 31). Risky along, deadly together. (The Washington Post)."},{"issue":"11","key":"10.1016\/j.jsat.2017.03.002_bb0100","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: Validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Medical Care"},{"issue":"5","key":"10.1016\/j.jsat.2017.03.002_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: Prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2017.03.002_bb0110","first-page":"613","article-title":"An ultra-brief screening scale for anxiety and depression: The PHQ-4","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2017.03.002_bb0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.drugalcdep.2008.07.017","article-title":"Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: Correlates of use, abuse and dependence","volume":"99","author":"Lavie","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.jsat.2017.03.002_bb0120","first-page":"2121","article-title":"Addiction: Part 1. Benzodiazepines\u2013side effects, abuse risk and alternatives","volume":"61","author":"Longo","year":"2000","journal-title":"American Family Physician"},{"key":"10.1016\/j.jsat.2017.03.002_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2121-11-2","article-title":"Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells","volume":"11","author":"Manthey","year":"2010","journal-title":"BMC Cell Biology"},{"issue":"4","key":"10.1016\/j.jsat.2017.03.002_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0740-5472(02)00271-4","article-title":"Trends in inpatient detoxification services, 1992\u20131997","volume":"23","author":"Mark","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.03.002_bb0135","series-title":"Helping patients who drink too much: A clinician's guide","author":"National Institute on Alcohol Abuse and Alcoholism","year":"2005"},{"issue":"4","key":"10.1016\/j.jsat.2017.03.002_bb0140","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","article-title":"Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment","volume":"102","author":"Nielsen","year":"2007","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.jsat.2017.03.002_bb0145","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.addbeh.2012.05.017","article-title":"A population-based cohort study of anxiety, depression, sleep and alcohol outcomes among benzodiazepine and z-hypnotic users","volume":"37","author":"Nordfjaern","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"Suppl. 2","key":"10.1016\/j.jsat.2017.03.002_bb0150","first-page":"28","article-title":"Benzodiazepine use, abuse, and dependence","volume":"66","author":"O'Brien","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.jsat.2017.03.002_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6409a1","article-title":"Controlled substance prescribing patterns\u2013Prescription Behavior Surveillance System, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"MMWR Surveillance Summaries"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/105504901750160484","article-title":"Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence","volume":"10","author":"Posternak","year":"2001","journal-title":"The American Journal on Addictions"},{"issue":"5","key":"10.1016\/j.jsat.2017.03.002_bb0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.08m04325","article-title":"Benzodiazepine use and driving: A meta-analysis","volume":"70","author":"Rapoport","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02939579","article-title":"Co-abuse of opiates and benzodiazepines","volume":"168","author":"Rooney","year":"1999","journal-title":"Irish Journal of Medical Science"},{"issue":"12","key":"10.1016\/j.jsat.2017.03.002_bb0175","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1360-0443.2000.951217858.x","article-title":"The nature of benzodiazepine dependence among heroin users in Sydney, Australia","volume":"95","author":"Ross","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2017.03.002_bb0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2015.12.018","article-title":"Correlates of overdose risk perception among illicit opioid users","volume":"159","author":"Rowe","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.03.002_bb0185","series-title":"The TEDS report: Substance abuse treatment admissions for abuse of benzodiazepines","author":"SAMHSA","year":"2011"},{"issue":"3","key":"10.1016\/j.jsat.2017.03.002_bb0190","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.drugalcdep.2013.04.006","article-title":"Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes","volume":"132","author":"Schuman-Olivier","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jsat.2014.07.001","article-title":"Comparing the life concerns of prescription opioid and heroin users","volume":"48","author":"Stein","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.03.002_bb0200","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.03.002_bb0205","series-title":"The DASIS report: Admissions for detoxification, 2001","author":"Substance Abuse and Mental Health Services Administration","year":"2004"},{"issue":"10","key":"10.1016\/j.jsat.2017.03.002_bb0210","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.addbeh.2013.05.008","article-title":"Treatment or \u201chigh\u201d: Benzodiazepine use in patients on injectable heroin or oral opioids","volume":"38","author":"Vogel","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"22","key":"10.1016\/j.jsat.2017.03.002_bb0215","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2017.03.002_bb0220","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","article-title":"Mechanisms of fatal opioid overdose","volume":"94","author":"White","year":"1999","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0225","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/10550887.2016.1107264","article-title":"Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain","volume":"35","author":"Wilder","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.jsat.2017.03.002_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/SAR.S15151","article-title":"Gender and racial\/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network","volume":"2010","author":"Wu","year":"2010","journal-title":"Substance Abuse and Rehabilitation"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721630530X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074054721630530X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:46:33Z","timestamp":1760039193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074054721630530X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":46,"alternative-id":["S074054721630530X"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.03.002","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}